Immediate Impact
4 from Science/Nature 62 standout
Citing Papers
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021 Standout
Works of M. Laakso being referenced
Conjugated Bile Acids Associate with Altered Rates of Glucose and Lipid Oxidation after Roux-en-Y Gastric Bypass
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| M. Laakso | 88 | 139 | 113 | 8 | 286 | |
| Heidi Karpen | 95 | 114 | 54 | 13 | 308 | |
| Emilie Balk-Møller | 121 | 126 | 95 | 7 | 331 | |
| Dirk Hagemann | 135 | 82 | 96 | 9 | 303 | |
| Lotte Simonsen | 175 | 125 | 36 | 7 | 270 | |
| H Schubert | 195 | 156 | 43 | 8 | 334 | |
| Steven L. Due | 146 | 131 | 81 | 11 | 312 | |
| Travis J. McKenzie | 77 | 128 | 70 | 12 | 301 | |
| R Zandomeneghi | 171 | 127 | 69 | 17 | 277 | |
| Elisa P. Jensen | 247 | 152 | 44 | 10 | 306 | |
| Mette Wildner‐Christensen | 81 | 170 | 59 | 11 | 314 |
All Works
Loading papers...